The largest database of trusted experimental protocols

In vivo ms fx pro

Manufactured by Carestream
Sourced in United States

The In Vivo MS FX PRO is a multipurpose laboratory instrument designed for small animal imaging. It utilizes advanced optical and digital technologies to capture high-resolution images and perform non-invasive, real-time analysis of biological processes within living subjects.

Automatically generated - may contain errors

10 protocols using in vivo ms fx pro

1

Kidney Imaging of Uterine Cell Engraftment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Kidneys were removed from both the control and UDC groups, and imaged with Carestream In Vivo MS Fx Pro (Carestream Health, USA) to capture X-ray and corresponding fluorescent images of the uterine cells that engrafted the kidney.
+ Open protocol
+ Expand
2

Imaging Extracted Organs with X-ray and GFP

Check if the same lab product or an alternative is used in the 5 most similar protocols
After organs were extracted, they were imaged with Carestream In-Vivo MS Fx Pro (Carestream Health, USA) to capture X-ray and corresponding GFP fluorescent images.
+ Open protocol
+ Expand
3

Imaging Uterine GFP Fluorescence

Check if the same lab product or an alternative is used in the 5 most similar protocols
Following organ extraction, the uteri were imaged with Carestream In-Vivo MS Fx Pro (Carestream Health, USA) fluorescent camera to capture GFP fluorescence images from the various peripartum and postpartum time points (E18.5, PPD1, PPD5, PPD10, nonpregnant).
+ Open protocol
+ Expand
4

Measuring IL-1β Tumor Fluorescence

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumors were removed from WT or IL-1β-DsRed BALB/c x C57BL/6 F1 mice and imaged immediately in the In-Vivo MS FX PRO (Carestream) in the Microscopy, Imaging, and Cytometry Resources (MICR) core. Fluorescent spectra collected for 30 seconds were merged with white light images. Mean DsRed fluorescence of each tumor slice was quantified using ImageJ densitometry software. Hematoxylin and eosin (H&E) staining was performed in the Animal Model and Therapeutics Evaluation Core. Histology images were captured using the SCN400 slide scanner and software (Leica Microsystems).
+ Open protocol
+ Expand
5

Tumor-targeted Oligomer Localization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Six-week-old female nu/nu mice were injected subcutaneously with MDB-MB-231 cells in PBS medium (5.0 × 106 cells per mouse). Tumor bearing mice were treated via tail vein injection with 10 nmole/mouse doses of HA-SMA-TPGS-S0456 and SMA-TPGS-S0456 oligomer respectively. Mice were imaged 4 h post-injection using a Carestream In Vivo MS FX PRO, Light Source: 400 W Xenon, Monochrome interlined, fixed lens (10×), CCD camera (13.8 × 13.8 cm / 2048 × 2048 px, 67 μmpx, 16 bit), excitation 750 nm, emission 830 nm wavelength for fluorescence, and X-ray images were captured. Both fluorescence and X-ray images of mouse was merged to demonstrate the localization of oligomers.
+ Open protocol
+ Expand
6

In Vivo Imaging of Photosensitizer Biodistribution

Check if the same lab product or an alternative is used in the 5 most similar protocols
4T1 tumor bearing
female BALB/c mice with an average tumor volume of 80 mm3 were divided into two groups and intravenously administered with
10 mg/kg of photosensitizer 1-PDT and 2-PDT, respectively. Mice (n = 3 for each time point)55 (link) were then
sacrificed at different time points (0, 15 min, 1, 3, 6, 24, 48, and
72 h post compound administration), and major organs such as liver,
spleen, lung, kidney, lymph nodes, skin, eye, and tumor tissues were
harvested. Organs and tissues were imaged using an In Vivo MS FX PRO
(Carestream Molecular Imaging, Woodbridge, CT) with an excitation
filter at 530 nm and emission filter at 600 nm. Mice treated with
saline were used as control. Fluorescence intensities of each organ
and tissue were quantified using Carestream Molecular Imaging software
5.0 (Woodbridge, CT).
+ Open protocol
+ Expand
7

Bioluminescent Imaging of Tumor Targeting

Check if the same lab product or an alternative is used in the 5 most similar protocols
Imaging of tumors and tracking of NDDs & ENDDs was performed using Carestream In-Vivo MS FX PRO using bio-luminescence imaging, which is based on the introduction and expression of a gene construct to produce a protein “luciferase”, using 4T1-luc2 orthotopic tumor model. NDDs & ENDDs were injected by tail vein into the tumor bearing mice. Following the injection, imaging of whole body and tumor area of animals were done at 0, 0.017, 0.25, 0.5, 1, 2, 3, 6, 8, 12 & 24 h. time points. Mice were anesthetized with 2% isoflurane using a 1 L/min O2 flow rate and placed in the prone position in the In-Vivo MS FX PRO. Bioluminescent imaging was performed using 745 nm excitation and 800 nm emission wavelengths. A 13 cm field of view (FOV) was used for whole body imaging and 6.6 cm for high resolution imaging of the tumor area. Targeting to the tumor vasculature by NDDs & ENDDs was quantified by drawing a region of interest (ROI) around the tumor area and measuring bioluminescence as total radiant efficiency, [p/s]/[µW/cm2].
+ Open protocol
+ Expand
8

Luciferase Expression in BALB/c Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
BALB/c mice bearing ∼50 mm3 TUBO tumors were treated with 108 PFU of Adv/Luc. Expression of luciferase is measured by live animal luminescence imaging using the In Vivo MS FX Pro (Carestream, Woodbridge, CT) after 150 mg/kg i.p. injection of the substrate D-luciferin (Caliper Life Sciences, 119222).
+ Open protocol
+ Expand
9

Bioluminescence Imaging in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were depilated and scanned after intraperitoneal delivery of 150 mg/kg of D‐luciferin. Animals were maintained under 1% gas anesthesia during scanning. Images were captured using In Vivo MS FX PRO (Carestream Health, Rochester, NY) and analyzed using Carestream MI SE version 5.0.6.20, 1 exposure of 90‐second duration.
+ Open protocol
+ Expand
10

DNA Fragmentation Assay for Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HeLa, SiHa, and C33A cells were plated at a density of 2.5 × 105 cells/ml for 24 h at 37°C under a 5% CO2 atmosphere. The cells were pre-incubated with or without N-acetylcysteine (5 mM) for 2 h. Afterward, the cells were treated with the proanthocyanidin polymer-rich fraction (IC50 and IC90 according to cell line) for 24 h. The cells were washed with PBS and lysed in a solution that contained Tris-HCl (10 mM: pH 8.0), EDTA (1 mM), NaCl (100 mM), SDS (0.5%), and proteinase K (20 mg/ml) at 65°C for 15 min. RNAse (1 mg/ml) was added and incubated at 37°C for 15 min. DNA was extracted by the phenol:chloroform:isoamyl alcohol method (25:24:1; v/v). DNA electrophoresis was performed on 1.0% agarose gel in Tris/boric acid buffer at 90 V for 1 h, and DNA was stained with SYBR safe DNA gel stain (Invitrogen). The molecular weight marker was the 100 bp DNA Ladder. Images were obtained using In vivo MS FX PRO (Carestream Molecular Imaging, Carestream Health).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!